While its not yet approved in the UK or Ireland, Retatrutide is currently in late-stage clinical trials, with availability expected from 2026 onwards
They may deliver more weight loss, work through different hormone pathways, and even offer a pill option for people who dont want injections
They improve glycemic control by inducing glycosuria, osmotic diuresis, and reduced glucose-sodium proximal tubule reabsorption
If you get some or all of your health coverage through Medicare, but you get your prescription drug benefit through a retirement plan from a previous employer or union, you may not be eligible for GLP-1 drug through Bridge
Its a really important site of effect, she says
Indirect effects warrant monitoring: gastric emptying may theoretically affect oral medication absorption, and weight loss may necessitate anticoagulant dose review